Literature DB >> 16872028

The outcome of direct current cardioversion (DCC) for the treatment of atrial fibrillation (AF) in a district general hospital in Ireland.

K P O'Rourke1, C Cotter, D Mullane, P Thorpe, P Sullivan.   

Abstract

BACKGROUND: Direct current cardioversion (DCC) is a method to control persistent AF, to facilitate a reduction in stroke risk. Although this is a frequently performed procedure, there are no available published data regarding its outcome in an Irish setting. AIMS: To determine the short- and long-term outcome of DCC, factors predicting a successful outcome, and its safety.
METHODS: Data relating to each DCC were collected retrospectively from patient notes over a 6.3 year-period, and subsequently entered into a Microsoft Access database before subsequent statistical analysis.
RESULTS: Forty-five consecutive unselected patients were identified, in which 59 DCCs were performed. Sinus rhythm (SR) was achieved immediately after DCC in 54/59 (91%) patients. There was a significant positive correlation between patient body weight and the energy level required to achieve SR (p=0.0001). No thromboembolic complications were noted. After a mean follow-up time of 12 +/- 13.7months, 30/45 (67%) had maintained SR. After univariate analysis, a number of important factors predictive of maintenance of SR at follow-up were identified.
CONCLUSION: DCC was found to be an effective method for short- and long-term control of AF, without thromboembolic complications, and patients with a favourable long-term outcome after DCC could conceivably be predicted on the basis of a methodical history, careful examination, simple investigations and pharmacological variables.

Entities:  

Mesh:

Year:  2006        PMID: 16872028     DOI: 10.1007/bf03167948

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  22 in total

1.  Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.

Authors:  A Capucci; G Q Villani; D Aschieri; A Rosi; M F Piepoli
Journal:  Eur Heart J       Date:  2000-01       Impact factor: 29.983

2.  Factors predicting maintenance of sinus rhythm after direct current cardioversion of atrial fibrillation and flutter: a reanalysis with recently acquired data.

Authors:  D O Arnar; R Danielsen
Journal:  Cardiology       Date:  1996 May-Jun       Impact factor: 1.869

3.  Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.

Authors:  D Roy; M Talajic; P Dorian; S Connolly; M J Eisenberg; M Green; T Kus; J Lambert; M Dubuc; P Gagné; S Nattel; B Thibault
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

4.  Higher energy synchronized external direct current cardioversion for refractory atrial fibrillation.

Authors:  W Saliba; N Juratli; M K Chung; M J Niebauer; O Erdogan; R Trohman; B L Wilkoff; R Augostini; K A Mowrey; G R Nadzam; P J Tchou
Journal:  J Am Coll Cardiol       Date:  1999-12       Impact factor: 24.094

5.  Electrical reversion of cardiac arrhythmias.

Authors:  B Lown
Journal:  Br Heart J       Date:  1967-07

6.  Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion.

Authors:  G Opolski; J Stanisławska; A Górecki; G Swiecicka; A Torbicki; T Kraska
Journal:  Clin Cardiol       Date:  1997-04       Impact factor: 2.882

7.  A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation.

Authors:  Kevin S Channer; Andrew Birchall; Richard P Steeds; Stephen J Walters; Wilf W Yeo; John N West; Rangasamy Muthusamy; Walter E Rhoden; Basil T Saeed; Phillip Batin; W Paul Brooksby; Ian Wilson; Simon Grant
Journal:  Eur Heart J       Date:  2004-01       Impact factor: 29.983

8.  Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study.

Authors:  P A Wolf; R D Abbott; W B Kannel
Journal:  Arch Intern Med       Date:  1987-09

Review 9.  Newer developments in the management of atrial fibrillation.

Authors:  S Nattel
Journal:  Am Heart J       Date:  1995-11       Impact factor: 4.749

10.  A review of direct current cardioversions for atrial arrhythmia.

Authors:  S D Johnston; T G Trouton; C Wilson
Journal:  Ulster Med J       Date:  1998-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.